Sawyers Charles Lazelle 4

What Happened
Charles Lazelle Sawyers, a director of BeOne Medicines Ltd. (ONC), was granted 18,980 restricted share units (transaction code A) on 2026-06-11. The award was recorded at $0.00 per share (no cash paid at grant). Under the filing footnote, these RSUs represent securities that will convert to shares subject to vesting rules.

Key Details

• Transaction date: 2026-06-11; Form 4 filed: 2026-06-15 (timely — within two business days).
• Grant: 18,980 restricted share units at $0.00 (total immediate cash value $0).
• ADS equivalence: Footnote states each American Depositary Share = 13 ordinary shares, so 18,980 ordinary shares = 1,460 ADS.
• Shares owned after transaction: not specified in the Form 4.
• Vesting / restrictions (Footnote F1): RSUs vest on the earlier of the first anniversary of the grant or the next annual general meeting; vesting stops if the director leaves the board unless accelerated under the Company's Independent Non‑Executive Director Compensation Policy (Footnote F1).
• Transaction type: Award/grant (A), not an open‑market purchase or sale.

Context
Restricted share units are a form of compensation that convert to actual shares if and when vesting conditions are met; they do not represent an immediate purchase or sale by the insider. Such awards are typically routine compensation for board service and are not by themselves a clear bullish or bearish signal about near‑term insider sentiment.